Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
Neok Bio has raised $75.0M in total funding. The most recent round was Series A. The last funding was announced in November 2025.
Neok Bio's investors include ABL Bio.
Neok Bio is headquartered in Palo Alto, United States.
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
Neok Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neok Bio — Funding & Investors." VCBacked, November 4, 2025, https://www.vcbacked.co/company/neok-bio. Accessed September 16, 2026.
VCBacked. (2025). Neok Bio — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/neok-bio
{{cite web |title=Neok Bio — Funding & Investors |url=https://www.vcbacked.co/company/neok-bio |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated